attenuated S. typhimurium carrying IL-15/IL-15Ra and engineered STING-encoding DNA plasmid ACTM-838
Term · Oncology and biomedicine · MLC-T-ONC-011294
A genetically modified attenuated Salmonella typhimurium strain carrying a DNA plasmid that encodes payloads consisting of IL-15plex, a complex of the immunostimulating cytokine interleukin (IL-15) and its receptor alpha unit (IL-15Ra), and an engineered, constitutively active stimulator of interferon genes (STING; transmembrane protein 173; TMEM173), with potential immunostimulatory and antineoplastic activities. Upon administration, attenuated S. typhimurium carrying IL-15/IL-15Ra and eSTING-encoding DNA plasmid ACTM-838 accumulates and replicates in the adenosine-rich tumor microenvironment (TME), and is internalized by the phagocytic antigen presenting cells (APCs). This activates innate immunity. Also, ACTM-838 expresses IL-15/IL-15Ra and eSTING, thereby delivering these payload directly into the TME. eSTING activates the STING pathway, which leads to the production of pro-inflammatory cytokines, including interferons (IFNs), enhances the cross-presentation of tumor-associated antigens (TAAs) by dendritic cells (DCs), and induces a cytotoxic T-lymphocyte (CTL)-mediated immune response against cancer cells. IL-15 stimulates the proliferation of natural killer (NK) cells, CTLs and memory T cells, which further induces an anti-tumor immune response. IL-15Ra complexed with IL-15 increases IL-15 signaling and IL-15 half-life upon expression.
| Identifier | MLC-T-ONC-011294 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | attenuated S. typhimurium carrying IL-15/IL-15Ra and eSTING-encoding DNA plasmid ACTM-838; attenuated S. typhimurium encoding IL-15plex and eSTING DNA plasmid ACTM-838 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011294",
"term": "attenuated S. typhimurium carrying IL-15/IL-15Ra and engineered STING-encoding DNA plasmid ACTM-838",
"field": "Oncology and biomedicine",
"definition": "A genetically modified attenuated Salmonella typhimurium strain carrying a DNA plasmid that encodes payloads consisting of IL-15plex, a complex of the immunostimulating cytokine interleukin (IL-15) and its receptor alpha unit (IL-15Ra), and an engineered, constitutively active stimulator of interferon genes (STING; transmembrane protein 173; TMEM173), with potential immunostimulatory and antineoplastic activities. Upon administration, attenuated S. typhimurium carrying IL-15/IL-15Ra and eSTING-encoding DNA plasmid ACTM-838 accumulates and replicates in the adenosine-rich tumor microenvironment (TME), and is internalized by the phagocytic antigen presenting cells (APCs). This activates innate immunity. Also, ACTM-838 expresses IL-15/IL-15Ra and eSTING, thereby delivering these payload directly into the TME. eSTING activates the STING pathway, which leads to the production of pro-inflammatory cytokines, including interferons (IFNs), enhances the cross-presentation of tumor-associated antigens (TAAs) by dendritic cells (DCs), and induces a cytotoxic T-lymphocyte (CTL)-mediated immune response against cancer cells. IL-15 stimulates the proliferation of natural killer (NK) cells, CTLs and memory T cells, which further induces an anti-tumor immune response. IL-15Ra complexed with IL-15 increases IL-15 signaling and IL-15 half-life upon expression.",
"synonyms": [
"attenuated S. typhimurium carrying IL-15/IL-15Ra and eSTING-encoding DNA plasmid ACTM-838",
"attenuated S. typhimurium encoding IL-15plex and eSTING DNA plasmid ACTM-838"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/attenuated-s-typhimurium-carrying-il-15-il-15ra-and-engineered-sting-encoding/"
}
Record 2,587 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.